Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
Pirfenidone (PFD) slows the progression of idiopathic pulmonary fibrosis (IPF) by inhibiting the exaggerated fibrotic response and possibly through additional mechanisms, such as anti-inflammatory effects. PFD has also been evaluated in other fibrosing lung diseases. Myocardial fibrosis is a common...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Radcliffe Medical Media
2022-04-01
|
| Serier: | Cardiac Failure Review |
| Online adgang: | https://www.cfrjournal.com/articleindex/cfr.2021.30 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|